The global non-invasive prenatal testing market size was estimated to be US$ 3.4 billion in 2022 and is expected to reach US$ 8.1 billion by 2032 at a CAGR of 9%.
Drastic changes in lifestyle has advanced the average maternal age across the globe. This change led to a rise in the cases of genetic abnormalities in new born kids. The abnormalities range from Down Syndrome, Turner Syndrome, Edwards Syndrome and so on. Apart from advanced maternal age, lack of care during pregnancy might also lead to chromosomal disorders. However, the percentage of careless is supremely low.
The doctors recommend non-invasive prenatal testing to expecting mothers for ruling out the possibility of any genetic abnormalities. Invasive methods of testing have been present for a while, however, there is relatively high risk associated with them. On the contrary, non-invasive prenatal testing is safe and simple. It is a conducted on the basis of blood sample of pregnant women. The plasma floating in the blood are enough for conducting the test.
The non-invasive prenatal test could be conducted in various gestation period throughout the pregnancy, however, the most accurate results are delivered during the first trimester. Adopting of minimally invasive diagnostic procedure at global level has been supportive in the growth of non-invasive prenatal testing market. The highest demand for non-invasive prenatal testing is observed for Down Syndrome application. It is the most commonly found chromosomal disorder worldwide.
As per the statistics released by Centers for Disease Control and Prevention (CDC), about 1 in every 700 babies born suffer from this disorder. This application segment will continue to be the most popular application of non-invasive prenatal testing throughout the forecast period. The diagnostics centers are getting more organized in terms of conducting business. This shift has been prominent across North America and Europe during the past decade. Asia Pacific region has comfortably picked this trend and embraced it positively. The advanced technology deployed across diagnostics centers and personal touch in the services offered has made them an obvious choice across the end users.
North America contributed a dominating share to the Global Non-Invasive Prenatal Testing Market in terms of value in 2019 and is expected to be a dominating geography throughout the forecast period. Increased number of cases with genetic disorders in new born kids is the prime cause for a high revenue generation across the region. Presence of more aware population and extended payer’s coverage for pregnancy risks are favorable for the non-invasive prenatal testing growth in North America Asia Pacific region is showing strong signs of potential for the non-invasive prenatal testing market. The growth of minimally invasive diagnostics procedures across Asian population is helping the spread of NIPT. This trend will continue throughout the forecast period.
Non-Invasive Prenatal Testing Market Value Share Analysis, by Geography (2022)
The report titled “Non-Invasive Prenatal Testing Market- Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 20223 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the Global Non-Invasive Prenatal Testing Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global Non-Invasive Prenatal Testing Market is segmented on the basis of technique, application, testing venue and geography. Based on technique, the global Non-Invasive Prenatal Testing Market is segmented into Polymerase Chain Reaction (PCR) and Next-generation Sequencing (NGS). Based on application the global Non-Invasive Prenatal Testing Market is segmented into Down Syndrome, Edwards Syndrome, Turner Syndrome, Patau Syndrome and Others. Based on testing venue the global Non-Invasive Prenatal Testing Market is segmented into hospitals, diagnostics centers and others. Based on geography, the global Non-Invasive Prenatal Testing Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Belgium, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, , Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, the UAE, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on non-invasive prenatal testing. Further, market share of prominent companies in the global Non-Invasive Prenatal Testing Market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the non-invasive prenatal testing companies. The global Non-Invasive Prenatal Testing Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the non-invasive prenatal testing business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global Non-Invasive Prenatal Testing market.
Major players active in the global Non-Invasive Prenatal Testing Market include BGI Genomics, Berry Genomics, Natera, Illumina, LabCorp, F. Hoffmann-La Roche Ltd., Medgenome Claria, LifeLabs Genetics, Eurofins Biomnis, Lilac Insights Pvt. Ltd., GENDIA, Dante Labs, Sequenom.
By Technique:
By Application:
By Testing Venue:
By Geography
The non-invasive prenatal testing market is expected grow at a CAGR of 9% from 2023 to 2032.
The non-invasive prenatal testing market size is expected to reach US$ 8.1 billion by 2032.
The non-invasive prenatal testing market was estimated to be US$ 3.4 billion in 2022.
Major players operating in the global Non-Invasive Prenatal Testing market include BGI Genomics, Berry Genomics, Natera, Illumina, LabCorp, F. Hoffmann-La Roche Ltd., Medgenome Claria, LifeLabs Genetics, Eurofins Biomnis, Lilac Insights Pvt. Ltd., GENDIA, Dante Labs, Sequenom.
Adopting of minimally invasive diagnostic procedure at global level has been supportive in the growth of non-invasive prenatal testing market.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved